Circulating Tumor DNA Analysis for Patients with Oncogene-Addicted NSCLC With Isolated Central Nervous System Progression
Author:
Funder
Roche
Boehringer Ingelheim
AstraZeneca
BMS
Merck
Novartis
Pfizer
Sanofi
Astellas
Astra Zeneca
Abbvie
Amgen
Biogen
Celgene
Lilly
GSK
Ignyta
Merck KGaA
MSD
Pharma Mar
Spectrum Pharmaceuticals
Publisher
Elsevier BV
Subject
Pulmonary and Respiratory Medicine,Oncology
Reference33 articles.
1. Brain metastases in oncogene-addicted non-small cell lung cancer patients: incidence and treatment;Remon;Front Oncol,2018
2. Leptomeningeal carcinomatosis in non-small cell lung cancer patients: a continuing challenge in the personalized treatment era;Remon;Cancer Treat Rev,2017
3. Clinical utility of cerebrospinal fluid cell-free DNA as liquid biopsy for leptomeningeal metastases in ALK-rearranged NSCLC;Zheng;J Thorac Oncol,2019
4. Frequent central nervous system failure after clinical benefit with epidermal growth factor receptor tyrosine kinase inhibitors in Korean patients with nonsmall-cell lung cancer;Lee;Cancer,2010
5. Molecular screening program to select molecular-based recommended therapies for metastatic cancer patients: analysis from the ProfiLER trial;Trédan;Ann Oncol,2019
Cited by 63 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. ROS1-rearranged non-small cell lung cancer: Understanding biology and optimizing management in the era of new approvals;Current Problems in Cancer;2024-12
2. Circulating tumor DNA to guide diagnosis and treatment of localized and locally advanced non-small cell lung cancer;Cancer Treatment Reviews;2024-09
3. ‘Plasma first’ approach for detecting epidermal growth factor receptor mutation in advanced non-small cell lung carcinoma;Journal of Cancer Research and Clinical Oncology;2024-07-27
4. Prolonged Clinical Benefit with Futibatinib in a Patient with FGFR Inhibitor–Pretreated FGFR2 Fusion–Positive Intrahepatic Cholangiocarcinoma: Case Report;OncoTargets and Therapy;2024-06
5. Exploring the Molecular Tumor Microenvironment and Translational Biomarkers in Brain Metastases of Non-Small-Cell Lung Cancer;International Journal of Molecular Sciences;2024-02-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3